163
Participants
Start Date
December 31, 2014
Primary Completion Date
September 22, 2017
Study Completion Date
September 22, 2017
CLT-008
Single intravenous infusion
G-CSF
Daily subcutaneous injections
Weill Cornell Medical College - New York Presbyterian Hospital, New York
Westchester Medical Center, Valhalla
West Penn Hospital, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Northside Hospital, Atlanta
Mayo Clinic Florida, Jacksonville
UF Health Shands Cancer Hospital, Gainesville
Indiana Blood and Marrow Transplantation Clinic, Indianapolis
University of Minnesota Physicians BMT Clinic, Minneapolis
Loyola University Medical Center, Maywood
Northwestern Medical Faculty Foundation, Chicago
University of Illinois Cancer Center, Chicago
The University of Chicago, Chicago
Washington University School of Medicine, St Louis
Kansas City Veterans Affairs Medical Center, Kansas City
Memorial Sloan Kettering Cancer Center, New York
The University of Texas MD Anderson Cancer Center, Houston
Ronald Reagan UCLA Medical Center, Los Angeles
University of California San Diego Moores Cancer Center, La Jolla
University of California, San Francisco Medical Center, San Francisco
Swedish Cancer Institute, Seattle
University of Massachusetts Worcester, Worcester
Lead Sponsor
Department of Health and Human Services
FED
Cellerant Therapeutics
INDUSTRY